| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 738 |
| 1 | ROSUVASTATIN | 226 |
| 2 | ALIROCUMAB | 116 |
| 3 | EZETIMIBE | 111 |
| 4 | INCLISIRAN | 102 |
| 5 | ATORVASTATIN CALCIUM | 98 |
| 6 | ASPIRIN | 76 |
| 7 | ASPIRIN 325 MG | 73 |
| 8 | ASPIRIN 81 MG | 73 |
| 9 | METFORMIN | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INCLISIRAN | 102 | 0.0121 |
| 1 | QUINAPRIL HYDROCHLORIDE | 41 | 0.0052 |
| 2 | ALIROCUMAB | 116 | 0.0045 |
| 3 | EVOLOCUMAB | 738 | 0.0045 |
| 4 | BEMPEDOIC ACID AND EZETIMIBE | 3 | 0.0042 |
| 5 | ROSUVASTATIN | 226 | 0.0026 |
| 6 | GLYBURIDE | 45 | 0.0019 |
| 7 | LOMITAPIDE MESYLATE | 7 | 0.0019 |
| 8 | LINAGLIPTIN | 29 | 0.0016 |
| 9 | EZETIMIBE | 111 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 851 |
| 1 | Dietary Cholesterol Absorption Inhibitor [EPC] | 121 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 101 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 76 |
| 5 | Sulfonylurea [EPC] | 57 |
| 6 | Thiazide Diuretic [EPC] | 51 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 45 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 30 |
| 9 | beta-Adrenergic Blocker [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 851 | 0.0330 |
| 1 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 6 | 0.0018 |
| 2 | Dietary Cholesterol Absorption Inhibitor [EPC] | 121 | 0.0013 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 30 | 0.0009 |
| 4 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 5 | Sulfonylurea [EPC] | 57 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 17 | 0.0003 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 9 | Carnitine Analog [EPC] | 1 | 0.0003 |